STERIS plc Stock News

YHB Investment Advisors Inc. grew its position in STERIS plc (NYSE:STE) by 4.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,373 shares of the medical equipment providers stock after buying an additional 55 shares during the quarter. YHB Investment Advisors Inc.s holdings []

Investors are optimistic about STERIS (STE) owing to strong segmental growth and bullish 2022 outlook.

The Zacks Medical - Instruments industry is growing on COVID-support business gains. TMO, STE and ARAY are set to gain the most.

The research report on the Global "Tabletop Autoclaves Market " provides the most up-to-date information on global market opportunities, challenges, trends, strategies, and latest advancements. It examines the development plans, as well as the current state, growth sectors, and future

The Endoscopy Visualization Systems & Components are strategies used in Endoscopic inspections like bronchoscopy, cystoscopy, etc. Endoscopy Visualization can be defined as a technique for inspecting, operating, and treating internal organs using devices to advance visualization from a detachment from

Los Angeles, United State: The global Endoscope Reprocessing Device market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section

Cambiar Investors LLC cut its stake in STERIS plc (NYSE:STE) by 1.1% in the third quarter, HoldingsChannel reports. The firm owned 46,044 shares of the medical equipment providers stock after selling 529 shares during the quarter. Cambiar Investors LLCs holdings in STERIS were worth $9,406,000 as of its most recent SEC filing. A number of []

Ortho Regenerative Technologies (OTCMKTS:ORTIF) and STERIS (NYSE:STE) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Profitability This table compares Ortho Regenerative Technologies and STERISs net margins, return on equity and return []

All of the issues that are possible to influence the market through the forecast period, as well as their suggestions for market growth, are comprised in the market investigation and understandings report. Current and future trends, as well as market

STERIS plc (Ireland) with ticker code (STE) now have 5 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 270 and 250 with the average target price sitting at 256. With the stocks previous close at 220.63 this indicates there is a potential upside of 16.0%. The day 50 moving average is 224.64 and the 200 moving average now moves to 208.23. The company has a market cap of $21,962m. Company Website: https://www.steris.com [stock_market_widget type="chart" symbol="STE" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

New Jersey, United Kingdom, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled "Veterinary Surgical Instruments Market By Instrument Type (Handheld Devices, Electrosurgery Instrument, Suture, Staplers, & Accessories, & Others), By Animal Type (Large Animal & Small Animal), By Application (Soft Tissue Surgery, Cardiovascular Surgery, Ophthalmic Surgery, Dental Surgery, Orthopedic Surgery, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 2026" in its research database "According to the latest research study, the demand of global Veterinary Surgical Instruments Market size & share expected to reach to USD 1,023.5 Million by 2026 from USD 783.9 Million in 2020, at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2021 to 2026" How Big is Veterinary Surgical Instruments Market? Report Overview & Coverage: Veterinary surgical instruments are the tools that are often used by veterinaries for performing surgeries which can be categorized into three broad categories Orthopedics (Bones, joints, and muscles), soft tissue surgery (skin, body cavities, and GI/respiratory tracts), and neurosurgery.

According to Fact.MRs analysis, 3M, Reckitt Benckiser, Kimberly-Clark Corporation, Cardinal Health, Bio-Cide International, BD, STERIS plc, and Johnson & Johnson, are identified as key players [read full press release]

Exchange Traded Concepts LLC purchased a new position in shares of STERIS plc (NYSE:STE) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,648 shares of the medical equipment providers stock, valued at approximately $541,000. A number of other hedge funds and other institutional investors []

Stratos Wealth Partners LTD. raised its position in shares of STERIS plc (NYSE:STE) by 3.9% in the third quarter, Holdings Channel reports. The firm owned 11,998 shares of the medical equipment providers stock after acquiring an additional 446 shares during the quarter. Stratos Wealth Partners LTD.s holdings in STERIS were worth $2,451,000 as of its []

Deroy & Devereaux Private Investment Counsel Inc. trimmed its holdings in STERIS plc (NYSE:STE) by 2.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,890 shares of the medical equipment providers stock after selling 290 shares during the quarter. Deroy & Devereaux Private Investment []